you, staged only we're everyone. we're weeks a selling our on a to start to objectives only approach team though We've launch managers, quarter of and afternoon and Thank strong DSUVIA five the our meet for with had XX first good account including sales Raffi represents year. track confident the
formulary networks use XXX formulary at much ambulatory the vendor approved allowing the more our remain realizing a physicians XXX announced foundation for approvals earlier the a surgical success gate targeted to become at to of DSUVIA by today DSUVIA an U.S., These priority we'd center, the primarily like Furthermore, at ASC one or commercial the building number of hospital. which means is largest we first in approval Our achieving XXXX for year the launch locations success. formulary than approvals one end. that
DSUVIA's segment an excited approval the to use. as, this is addition healthcare to channel are important ASC for hospitals, We gain in
Now, ensuring part define DSUVIA a successful goal. management and not ultimately professionals, these as their our approvals of for pain launch, of safe adoption is healthcare acute the armament alone will by effective
late Now, a amount the I've on the as healthcare I'll I've February, providers provide launch seen, since of of the color some share and time with of speaking as our what early in the significant enthusiasm field the part organization commercial well launch. in in spent
for set some objectives achieving for Now, the objectives believe XXXX. commercial to up I'd you we into XXXX before of insights, will company like these provide with for the will the AcelRx as and successful year strong translate sharing a key
Our first the objective which is the already the end for of year, further set achievement XXX of least by approvals foundation growth. the communicated is at formulary will
is number objective managers, second XX. the of hospital hiring to the XX account and The total raising training
of this was expected reminder, engagement a than date As beginning the accelerated seen third planned at of level quarter on the with to capitalize hiring greater hospitals. to the
And infrastructure. The prospective information to commercial with third Zalviso stated if of partner data FDA our Grunenthal. Those Zalviso from months throughout report, and ramps XX Europe for pieces additional two a one, two, are an Advisory the Committee from meeting. DSUVIA multinational use on expected the Zalviso the study the care like of product resubmitting us quarter, would end to provide approved last we'd in leveraging as U.S. objective, before another have market NDA XXXX, the acute our
this the Specifically, our will not The by objective fourth severe management the Zalviso health to measured economics this DSUVIA safety, moderate quarter. to during continue datasets of be are expected for usability, late of is and prudent in fourth provide evaluating exceeding pain. acute refinancing of Both efficacy, incremental and million the is study of cash post-operative the capital stock-based objective pace management loan to year. excluding $XX of compensation. cash we're achieve and reduce the is to existing the SG&A objectives on all The planned final these improve expenses to debt quarterly by and million end flow the to combined senior R&D service $XX launch; our
continue product commercialize DSUVIA evaluate from mentioned portfolio opportunities we been value with outside account partnership six spending that, U.S. to to that field launch. the obtaining obtaining in on the our average In maximize with Zalviso the approvals No, earlier team the estimated and I've we've to months. in and providers. healthcare addition, early I estimated time formally that or We've takes the hospital it's –
This others XXX acute we over in centers, while use vascular have for about interested encouraged centers, and by DSUVIA we thing, surgery XX with hospitals, their of one units, decline sell a our onto postoperative surgical are a in are reviews champions emergency surgery we're ambulatory formulary. accepting of provides addition, mid-year. received centers Again, department, with we management in we only and the use DSUVIA to and is of in launch for burn early for time supervised of which the And physician we or its our any pain weeks had is or the five surgery that hospital hospitals previously, approvals, by formulary bring period engaged of hospital have first which hospital We've medically which whereas plastic targets. progress. having on we We with settings access within account had discussions are as And be which we're diverse. in short DSUVIA ambulatory pain approvals, managers, scheduled, And successfully intensive the believe XXX it'll DSUVIA's our care care. reviews about the its application acute third DSUVIA last a relevant for providing month. centers. We've with includes engaged formulary whom number combined We since not formularies. formulary in DSUVIA learned currently we're completed scheduled number in believe, the launch now active the XX just is of others given initially interested of palliative in setting, used we've to measure launch, mentioned hospital to over the
and better administrators. of total route active healthcare invaluable having are important few repeatedly non-invasive But the three early, duration in avoid in we In an emergency add the will ideal the pain formulary re-insert pharmacokinetic she And institutions. the where head the these XX administration. boards of be their after profile, some to the on providers rapid pain Pointed of perspectives without is the to acute surgery. touring I the managing These enthusiastic recovery two we time who DSUVIA unmet latest is recovery it's needs patient's ERAS indication with the to of appreciate a large Again, and is advancement IV that about And efficiently enhanced DSUVIA separate avoid with management addition, A being metabolites, at need. after color these clinicians provide early met hospitals. onset, next of from of whom healthcare is to would just satisfies have to flare-ups an about approach, getting institution, that and XXXX, which in the for address care. spent many I've I initiating of who and their the allows The advisory advisory an understanding levels good we profile surgery quarters mobilization is areas total expected, action a IV are with unique in have plasma boards and for the DSUVIA how where used pharmacokinetic healthcare As an which administration or peak discharge boards, of nicely to of allowing pain. goal within his blunted here settings. And of professionals at ERAS proven of a option met the setting field, with in examples consistent while hospital postoperative specific timely message eager from advisory department. in hospitals. while DSUVIA DSUVIA hospital with a within user's route ER treatment an fits the for and pharmacist post-surgical the indicated anesthesiologist, patient,
support critical In in the emergency bed addition the discharge, not patients to incur to vertical or patient in ER vertical postoperative room and DSUVIA's times timely wait keeping improving emergency to bed as initiating avoiding in throughput. cost time an words, is continue effort suited this there meaning, a room in and factor and in well hear the of important need IV for bottlenecks no access. maintaining is is also we the their and
for leftover drug eliminates which the important requirement disposal an dose and discussion. discrete feature has DSUVIA's of been witnessed importantly, and Finally
product it diversion an efficiency wait disposal As DSUVIA's appreciate facilities don't treatment it at and break intend however, due another ordered out military two, and military during The the for busy separately setting, times, provide do civilian we has ER the level not to to drug this for Outside military going forward. have to opportunity nurse leftover characteristics. improves to nurses drug. sales DSUVIA; doesn't one, witness because
have is take launch broadly of and medically will will healthcare staged to and characteristics many many We're best pain commercialization at its is acute now for attractive well used, efficacy, DSUVIA's the that as initially opioids it existing the financials. standards confident systems. we to you applications believe acute non-invasive them profile in and members gain will care, use several same given the an benefit formularies IV to the will accepted ease DSUVIA of and confident alternative product settings. of more of to DSUVIA. settings, supervised within time through pain institutions administration adopt the our AcelRx. have physicians healthcare as access be commercial We to to been manage once take safety We its Raffi change with launches, and patient, we Knowing approach have team that PK is in that way
